Quantcast

High Throughput Screening (HTS) Market Worth $19,626.54 Million by 2018

February 4, 2014

DALLAS, February 4, 2014 /PRNewswire/ –

According to the new market research report, the “High Throughput Screening (HTS)
Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free,
Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology,
Stem Cell), by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) – Forecast
to 2018″, analyzes and studies the major market drivers, restraints, and opportunities in
North America, Europe, Asia, and Rest of the World.

Browse 75 tables and 23 figures spread through 245 pages and in-depth TOC on “High
Throughput Screening (HTS) Market”.

http://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html

Early buyers will receive 10% customization on this report.

This report studies the global high throughput screening (HTS) market over the
forecast period of 2013 to 2018. The global HTS market was valued at an estimated
$13,735.88 million in 2013 and is poised to grow at a CAGR of 7.4% from 2013 to 2018, to
reach $19,626.54 million by 2018.

A number of factors such as technological innovations, open innovation models adopted
by pharmaceutical companies, increasing drug discovery initiatives by academic
institutions, and huge capital investments in the HTS technology by organizations are
driving the growth of the HTS market. Moreover, the presence of a large untapped market in
emerging countries and the incessant rise in outsourced drug discovery services especially
in China and India are the various growth opportunities in this market. However, the
capital intensive nature of HTS and difficulties in assay development for novel target
classes are the factors that are curbing the growth of this market.

The HTS Market is broadly classified into five segments, namely, technology, products,
applications, end users, and geography. In the applications segment, the target
identification market held the largest share of 45% in 2013. The availability of large
compound libraries and well-equipped HTS laboratories, and technological advancements are
the major factors driving the growth of this market. However, the primary screening market
is poised to grow at the highest CAGR. The availability of a large number of potential
lead compounds, emergence of several new detection technologies, and availability of novel
primary and stem cell phenotypes are the factors that are responsible for the growth of
this market segment. The growth in the outsourcing of drug services, especially in the
Asian region, is a major reason for the high growth of the HTS market. In the end-users
market, the pharmaceuticals segment dominated the market in 2013, with a market share of
around 45%. In the technology market, the label-free technology segment is expected to
register the highest growth in the forecast period. Label-free technology offers the
direct detection ability, which was not possible with cell-based assays. Furthermore, it
helps in reducing drug failure due to toxicity and can be applied to a majority of drug
classes.

The global High Throughput Screening Market is dominated by North America, followed by
Europe, Asia, and the Rest of the World (RoW). The large market share of the North
American region is attributed to the increased investments by drug discovery firms for the
promotion and advancement of technologies and increasing number of collaborations among
companies and academia to develop and distribute innovative HTS products.

The major players in the HTS market include Agilent Technologies (U.S.), PerkinElmer
(U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich
Corporation (U.S.), and Tecan group (Switzerland), among others.

Browse related reports

In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems]
[Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) &
Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] -
Forecast To 2017

http://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html

Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals
(Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug
Delivery Devices (Microneedles, Micropumps), IVD (POC) – Global Trends & Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/microfluidics-market-1305.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S.
We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and
custom research services. MarketsandMarkets covers thirteen industry verticals; including
advanced materials, automotives and transportation, banking and financial services,
biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power,
food and beverages, industrial automation, medical devices, pharmaceuticals, agriculture
industry, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.

        Contact:
        Mr. Rohan
        North - Dominion Plaza
        17304 Preston Road
        Suite 800, Dallas, TX 75252
        Tel: +1-888-600-6441
        Email: sales@marketsandmarkets.com
        Visit MarketsandMarkets Blog @

http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology

        Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets


Source: PR Newswire



comments powered by Disqus